Danica Holley
About Danica Holley
Independent director since August 2021; age 52 as of April 14, 2025. Chief Operating Officer of Global Medical REIT Inc. (public net-lease medical office REIT) since April 2015, with prior international program management and business development roles. Serves on the board of Theralink Technologies, Inc. and has led global health initiatives as Executive Director of Safe Blood International Foundation since 2008 .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| WorldSpace, Inc. | Director of Strategy, Corporate Business Development | 1997–2000 | International expansion, corporate BD |
| ISI Professional Services | Director of Marketing (Corporate/Business) | 2000–2001 | Marketing leadership |
| Tanzus Development | Director of Administration | 1996–1997 | International trade operations |
| SK&I Architectural Design Group, LLC | Director of Administration | 2003–2007 | Operations for residential/mixed-use design |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Global Medical REIT Inc. (NYSE: GMRE) | Chief Operating Officer | Apr 2015–present | Public REIT executive |
| Theralink Technologies, Inc. (OTC) | Director | May 2022–present | Precision medicine/proteomics company |
| Safe Blood International Foundation | Executive Director | Apr 2008–present | Led Africa/Asia initiatives incl. Ebola response |
Board Governance
- Committees: Audit, Compensation, and Nominating & Governance (member of all three; not a chair) .
- Independence: Determined independent under NYSE American rules; majority of Board is independent .
- Attendance: Board held 9 meetings in FY2024; Audit 5, Compensation 7, Nominating & Governance 3; each director (other than Mr. Greiwe) attended at least 75% of aggregate meetings—Holley met the threshold .
- Election results (2025 AGM): Holley received 29,773,964 votes FOR; 235,461 WITHHELD (high support) .
- Ownership guidelines: Non-employee directors must hold ≥4× annual director compensation; company reports all directors are in compliance .
- Board leadership: Combined Co‑Chair/CEO structure counterbalanced by independent Co‑Chair and independent committee chairs; Holley’s presence across all three committees supports oversight .
Fixed Compensation
| Component (FY2024) | Amount | Notes |
|---|---|---|
| Annual Director Retainer (non-chair) | $70,000 | Standard independent director retainer |
| Cash Fees Paid | $28,000 | 40% of retainer paid in cash |
| Stock Awards (RSUs, grant-date fair value) | $42,000 | 60% of retainer in RSUs; RSUs vest in full at 1-year anniversary of grant |
| Committee Chair Fees | $0 | Chairs receive $10,000 (Comp/N&G) or $15,000 (Audit/Independent Co‑Chair); Holley is not a chair |
Performance Compensation
BEEP does not disclose performance-conditioned pay for directors; however, as a Compensation Committee member, Holley oversees executive incentive plans and their metrics:
| Plan | Metric | Threshold | Target | Maximum | Measurement Period |
|---|---|---|---|---|---|
| Short-term Incentive (NEOs, FY2024) | Net Operating Income (NOI) | $23.2M | $23.9M | $25.9M | FY2024 |
| Short-term Incentive (NEOs, FY2024) | Adjusted EBITDA Plus | $16.2M | $17.1M | $19.1M | FY2024 |
| Long-term Incentive (NEOs) | TSR vs Russell 2000 | 35th percentile (50% vest) | 55th percentile (100% vest) | 75th percentile (200% vest) | Jan 10, 2024–Jan 8, 2027 |
Additional governance features relevant to performance oversight:
- Independent compensation consultant (Farient Advisors) engaged in 2024; committee concluded no conflicts of interest .
- Company clawback policy for incentive-based compensation applicable to Executive Officers (stock price/TSR included); no recoveries required for 2023/2024 revisions .
Other Directorships & Interlocks
| Company | Type | Role | Potential Interlock/Conflict |
|---|---|---|---|
| Theralink Technologies, Inc. | Public (OTC) | Director | No disclosed business with BEEP |
| Global Medical REIT Inc. | Public (NYSE) | COO | Different sector (healthcare real estate); no disclosed ties to BEEP |
No related-party transactions disclosed involving Holley. Board-level related-party items (e.g., credit facility and unit conversions with entities managed by Director Osher; parking facilities operated by CEO’s family business) warrant continued oversight but do not implicate Holley directly .
Expertise & Qualifications
- Public company REIT operations and capital markets experience as COO (GMRE) .
- International program management, procurement, and startup rollouts (Africa/Asia health initiatives; satellite/media; consulting) .
- Financial literacy and governance: audit, compensation, and nominating/governance committee service at BEEP .
Equity Ownership
| Holding (as of Mar 31, 2025 unless noted) | Amount | Notes |
|---|---|---|
| Common Stock | 44,651 shares | <1% ownership of outstanding shares |
| Operating Company Common Units (vested LTIPs convertible ≤60 days) | 7,717 units | Convertible into Common Units; reflects vested LTIP Units |
| RSUs held (as of Dec 31, 2024) | 29,168 units | Director RSUs from retainer; time-based vesting |
| LTIP Units held (as of Dec 31, 2024) | 10,088 units | Profits interest units in Operating Company |
| Ownership Guideline Compliance | In compliance | ≥4× annual compensation requirement |
| Hedging/Pledging | Hedging prohibited; no pledging disclosures | Insider trading policy bans hedging derivatives; no pledging noted in proxy |
Governance Assessment
- Strengths: Broad operational and international experience; independent status; service across all three key committees; adequate meeting attendance; strong shareholder support at 2025 AGM; equity alignment via RSUs/LTIPs; oversight of robust performance metrics for executives; use of independent compensation consultant; clawback policy and hedging prohibition .
- Watch items: Board-level related-party exposures (Harvest/No Street credit facility and conversions; Park Place Parking operations tied to CEO’s family) require continued audit/independent oversight; combined Co‑Chair/CEO structure necessitates strong committee counterbalances. No Holley-specific related-party transactions identified .
RED FLAGS (None specific to Holley disclosed): No director-level conflicts, low attendance, or pay anomalies disclosed for Holley; monitor Board-level related-party arrangements and leadership concentration .